Blog
Real-world study finds 1 in 7 patients returned to Humira after switching to an adalimumab biosimilar
A real-world study found 16% of patients switched back to Humira after starting an adalimumab biosimilar, highlighting transition challenges.
Understanding real-world patterns of increasing oral semaglutide dose for obesity
Shingrix at 50: A good-news story for adult vaccination, healthy aging, and real-world study design
Shingrix vaccination is rising among newly eligible adults, but access gaps remain
Progesterone-containing hormone replacement therapy use is rising
Progesterone-containing hormone replacement therapy use is rising. Truveta Research found prescribing increased more than fourfold between 2018 and 2026.
Generating synthetic clinical notes to improve biomedical AI
ASCO 2026: Multi-agent LLM framework predicts one-year risk across multiple cancers
